Health Care Portfolio Series 5

The Trust consists of 42 stocks classified as being in the Health Care Sector by the Global Industry Classification Standard (“GICS”). The Trust is diversified across the Health Care Sector, which includes the following industries: Biotechnology, Health Care Equipment and Supplies, Health Care Providers and Services, Health Care Technology, Life Sciences Tools and Services, and Pharmaceuticals. The Sponsor selects stocks for the portfolio that it believes have the potential to achieve the Trust’s investment objective.

The Sponsor selects U.S. traded stocks that it believes are core holdings of a well-diversified health care portfolio. To select the portfolio, the Sponsor follows a very disciplined process that includes both quantitative and qualitative analysis. The Sponsor begins with the approximately 550 stocks of companies that are classified as being in the Health Care Sector, traded on U.S. exchanges, and are either components of the Russell 3000® Index (“R3K”) or have market capitalizations larger than the smallest company within the R3K. The Sponsor then reduces the size of this universe to approximately 250 stocks by performing quantitative screening which is based on factors such as, but not limited to:

• Valuation. The Sponsor may screen for reasonably valued stocks based on measures such as price to earnings, price to book, and price to cash flow.
• Growth. The Sponsor may screen for companies with a history of better than average growth of revenues and earnings.
• Profitability. The Sponsor may screen for companies with a history of consistent and high profitability as measured by return on assets, return on equity, gross margin and net margin.

The Sponsor then reduces the 250 securities to 42 stocks by performing qualitative analysis based on factors such as, but not limited to:

• Balance Sheet. The Sponsor favors companies which possess overall financial strength and exhibit balance sheet improvements relative to their peers and the marketplace.
• Industry Leadership. The Sponsor favors companies which possess a strong competitive position among their domestic and global peers.
• Valuation. The Sponsor favors stocks for which valuations appear to be attractive based on measures such as price to earnings, price to book, and price to cash flow.
• Growth. The Sponsor favors companies with a history of (and prospects for) better than average growth of revenues and earnings.
• Profitability. The Sponsor favors companies with a history of (and prospects for) consistent and high profitability as measured by return on assets, return on equity, gross margin and net margin.

The Russell 3000® Index

The Russell 3000® Index offers investors access to the broad U.S. equity universe representing approximately 98% of the U. S. market. The Russell 3000® is constructed to provide a comprehensive, unbiased, and stable barometer of the broad market and is completely reconstituted annually to ensure new and growing equities are reflected.

As with all investments, you can lose money by investing in this Trust. The Trust also might not perform as well as you expect. This can happen for reasons such as these:

• Stock prices can be volatile. The value of your investment may fall over time. Market value fluctuates in response to various factors. These can include stock market movements, purchases or sales of securities by the Trust, government policies, litigation, and changes in interest rates, inflation, the financial condition of the securities’ issuer or even perceptions of the issuer.
• The Sponsor does not actively manage the portfolio. The Trust will generally hold, and may continue to buy, the same stocks even though the stock’s outlook, market value or yield may have changed.
• Share prices or dividend rates on the stocks may decline during the life of the Trust. This may result in a reduction of the value of your units.
• The Trust includes stocks issued by companies in the health care sector. General risks of companies in the health care sector include extensive competition, generic drug sales or the loss of patent protection, product liability litigation and increased government regulation.
• The Trust includes securities issued by small-capitalization and mid-capitalization companies. These stocks customarily involve more risk than large-capitalization or more seasoned stocks. Small-capitalization and mid-capitalization companies may have limited product lines, markets or financial resources and may be more vulnerable to adverse general market or economic developments.
• The Trust invests in U.S. listed foreign securities and American Depositary Receipts (“ADRs”). The Trust’s investment in U.S. listed foreign securities and ADRs presents additional risk. ADRs are issued by a bank or trust company to evidence ownership of underlying securities issued by foreign corporations. Securities of foreign issuers present risks beyond those of domestic securities. More specifically, foreign risk is the risk that foreign securities will be more volatile than U.S. securities due to such factors as adverse economic, currency, political, social or regulatory developments in a country, including government seizure of assets, excessive taxation, limitations on the use or transfer of assets, the lack of liquidity or regulatory controls with respect to certain industries or differing legal and/or accounting standards.
• Inflation may lead to a decrease in the value of assets or income from investments.

See “Investment Risks” in Part A of the prospectus and “Risk Factors” in Part B of the prospectus for additional information.